Imuno – Jan-Jaap Verhoef
At Imuno, they combine the power of genetic sequencing and structural modelling to select cancer-specific epitopes – also known as neo-epitopes – on the cancer cell surface of a patient’s tumour. The discovery platform can rapidly identify neo-epitopes that are truly unique, enabling Imuno to lead the way to design patient-specific immunotherapies.
During the program, Imuno won the startup pitch contest at BioPartner 5’s starters day. Two months later, Imuno received a total of €300.000 from UNIIQ - Finance for the Future, together with Libertatis Ergo Holding B.V. (LEH). They have also recently been featured in the Leidsch Dagblad, read the article here.
EXIT071 – Yuliya Shakalisava
Exosomes have a huge potential for non-invasive diagnostics and novel therapeutics. At EXIT071 they develop microfluidic technology that allows for the isolation and analysis of exosomes with high purity and in high-throughput, automated format. It will be used in diagnostic applications and in product development of exosome therapeutics.
They were awarded the NWO Take Off 1 grant to create an innovative business in the area of exosomes analysis. At the end of 2021, EXIT071’s exclusive license agreement on dzITP technology for exosomes analysis was signed.
RespiQ – Vitalii Vorkov
RespiQ’s mission is to positively impact the health of millions by providing accurate, non-invasive and affordable technology for early detection of health issues, breath by breath. RespiQ’s handheld device checks your breath for biomarkers that are only present if your digestive system can’t digest a food type.
In July last year, RespiQ was granted an early stage financing ‘Vroege Fase Financiering’ (VFF) by The Netherlands Enterprise Agency (RVO). This was followed by them being awarded the Rabobank Innovation Loan.
Doser - Arjan van Unen, Niels Ouwerkerk, Wouter van Unen, Thomas de Boer
Doser ensures that patients receive more effective treatments with fewer side effects. They do this by developing a 3D printer that uses special technology to produce a customized pill for each patient. In this way, pharmacists can make personalized medication.
During the program, their Medicine 3D Printer was officially added to the LUMC’s GMP licence. Doser recently received the NWO Take off phase 2 grant at 250,000 euros for the development of cartridges for their MedPrint medicine 3D printer.
Panorama Laboratories - Maximillian Green, Jan Zender
Biotech R&D requires huge amounts of documentation for compliance and decision making. Max and Jan from Panorama are building the first documentation system which automatically records pipette steps without needing any input from the person using the pipette. This system does not rely on human-dependent journaling.
Throughout the program, they have been hard at work pilot testing their system. Recently, Panorama was selected to receive the Rabobank Innovation Loan which will be used to improve their automated documentation systems for biotech labs, grow their team and expand pilot activities.
<aside> ❗ Be a part of our participant stories by signing up for the program!
</aside>